Coming out of Chapter 11, Aegerion jumps into welcome arms of Irish ...

09/25/19

Coming out of Chapter 11, Aegerion jumps into welcome arms of Irish pharma with big plans, fresh $60M for its drugs  Endpoints News

Is Regeneron losing its R&D mystique? Analyst discounts big biotech's runner-up development strategy in an increasingly commoditized world. Nobody disses ...

[more]